Jim Simons Aravive, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.25 - $1.92 $76,915 - $118,141	61,532 Added 40.29%	214,245 $270,000
Q1 2023 May 12, 2023	SELL	$1.29 - $2.46 $31,992 - $61,008	-24,800 Reduced 13.97%	152,713 $305,000
Q4 2022 Feb 13, 2023	SELL	$1.2 - $1.83 $230,779 - $351,938	-192,316 Reduced 52.0%	177,513 $234,000
Q3 2022 Nov 14, 2022	SELL	$0.61 - $1.03 $3,120 - $5,269	-5,116 Reduced 1.36%	369,829 $302,000
Q2 2022 Aug 12, 2022	BUY	$0.93 - $1.9 $90,317 - $184,520	97,116 Added 34.96%	374,945 $370,000
Q1 2022 May 13, 2022	SELL	$1.85 - $2.75 $119,325 - $177,375	-64,500 Reduced 18.84%	277,829 $536,000
Q4 2021 Feb 11, 2022	BUY	$2.19 - $4.07 $133,809 - $248,677	61,100 Added 21.73%	342,329 $750,000
Q3 2021 Nov 12, 2021	BUY	$3.67 - $5.8 $13,946 - $22,040	3,800 Added 1.37%	281,229 $1.05 Million
Q2 2021 Aug 13, 2021	BUY	$4.65 - $6.42 $294,810 - $407,028	63,400 Added 29.62%	277,429 $1.66 Million
Q1 2021 May 13, 2021	SELL	$5.11 - $9.24 $160,392 - $290,025	-31,388 Reduced 12.79%	214,029 $1.41 Million
Q4 2020 Feb 10, 2021	SELL	$4.36 - $6.51 $1.19 Million - $1.78 Million	-272,702 Reduced 52.63%	245,417 $1.38 Million
Q3 2020 Nov 13, 2020	BUY	$4.7 - $12.06 $696,746 - $1.79 Million	148,244 Added 40.08%	518,119 $2.44 Million
Q2 2020 Aug 13, 2020	SELL	$5.18 - $14.81 $887,883 - $2.54 Million	-171,406 Reduced 31.67%	369,875 $4.31 Million
Q1 2020 May 14, 2020	BUY	$3.5 - $13.77 $769,919 - $3.03 Million	219,977 Added 68.46%	541,281 $3.12 Million
Q4 2019 Feb 13, 2020	BUY	$6.21 - $14.02 $923,085 - $2.08 Million	148,645 Added 86.09%	321,304 $4.39 Million
Q3 2019 Nov 13, 2019	BUY	$5.2 - $8.68 $126,848 - $211,739	24,394 Added 16.45%	172,659 $1.3 Million
Q2 2019 Aug 12, 2019	BUY	$5.65 - $7.5 $101,796 - $135,127	18,017 Added 13.83%	148,265 $890,000
Q1 2019 May 14, 2019	BUY	$3.35 - $8.27 $4,174 - $10,304	1,246 Added 0.97%	130,248 $917,000
Q4 2018 Feb 13, 2019	BUY	$3.23 - $8.7 $416,676 - $1.12 Million	129,002 New	129,002 $454,000

Others Institutions Holding ARAV

# of Institutions

Shares Held

28.1K

Call Options Held

Put Options Held

View Full List

About Aravive, Inc.

Ticker ARAV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,518,300
Description
Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...

More about ARAV

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account